참고문헌
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer Journal for Clinicians 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
- The International Agency for Research on Cancer, Schistosomes, Liver Flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans, No. 61. p1-241, Lyon, 1994.
- Correa P. A human model of gastric carcinogenesis. Cancer Research 1988;48(13):3554-3560.
- Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. The New England Journal of Medicine 1991;325(16):1127-1131. https://doi.org/10.1056/NEJM199110173251603
- Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. The New England Journal of Medicine 2018;378(12):1085-1095. https://doi.org/10.1056/nejmoa1708423
- Lee YC, Chiang TH, Chou CK, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology 2016;150(5):1113-1124.e5. https://doi.org/10.1053/j.gastro.2016.01.028
- Kim SG, Jung H-K, Lee HL, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 Revised Edition. KJG 2013;62(1):3-26.
- Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015;64(9):1353. https://doi.org/10.1136/gutjnl-2015-309252
- El-Serag HB, Kao JY, Kanwal F, et al. Houston consensus conference on testing for Helicobacter pylori infection in the United States. Clinical Gastroenterology and Hepatology 2018;16(7):992-1002.e6. https://doi.org/10.1016/j.cgh.2018.03.013
- Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the maastricht V/Florence consensus report. Gut 2017;66(1):6-30. https://doi.org/10.1136/gutjnl-2016-312288
- Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. The American Journal of Gastroenterology 2017;112(2):212-239. https://doi.org/10.1038/ajg.2016.563
- Bae SE, Choi KD, Choe J, et al. The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations. Helicobacter 2018;23(2):e12464. https://doi.org/10.1111/hel.12464
- Choi IJ, Kim CG, Lee JY, et al. Family history of gastric cancer and Helicobacter pylori treatment. The New England Journal of Medicine 2020;382(5):427-436. https://doi.org/10.1056/nejmoa1909666
- Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 2014;348:g3174. https://doi.org/10.1136/bmj.g3174
- Ford AC, Yuan Y, Forman D, Hunt R, Moayyedi P. Helicobacter pylori eradication for the prevention of gastric neoplasia. the cochrane database of systematic reviews. The Cochrane Library 2020;7(7):CD005583.
- Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut 2020;69:2113-2121. https://doi.org/10.1136/gutjnl-2020-320839
- Kim N, Park RY, Cho SI, et al. Helicobacter pylori infection and development of gastric cancer in Korea: long-term followup. Journal of Clinical Gastroenterology 2008;42(5):448-454. https://doi.org/10.1097/MCG.0b013e318046eac3
- Shichijo S, Hirata Y, Niikura R, et al. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointestinal Endoscopy 2016;84(4):618-624. https://doi.org/10.1016/j.gie.2016.03.791
- Chen H-N, Wang Z, Li X, Zhou Z-G. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer 2016;19(1):166-175. https://doi.org/10.1007/s10120-015-0462-7
- Massarrat S, Haj-Sheykholeslami A, Mohamadkhani A, et al. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients. Archives of Iranian Medicine 2012;15(11):664-669.
- Hwang YJ, Kim N, Lee HS, et al. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication-a prospective study for up to 10 years. Alimentary Pharmacology & Therapeutics 2018;47(3):380-390. https://doi.org/10.1111/apt.14424
- Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097
- Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical Research ed) 2011;343:d5928. https://doi.org/10.1136/bmj.d5928
- Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. Journal of the National Cancer Institute 2000;92(23):1881-1888. https://doi.org/10.1093/jnci/92.23.1881
- Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291(2):187-194. https://doi.org/10.1001/jama.291.2.187
- Saito D. H. pylori infection and gastric cancer: Japanese intervention trial. Nihon Rinsho Japanese Journal of Clinical Medicine 2005;63 Suppl 11:35-40.
- Wong BC, Zhang L, Ma JL, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 2012;61(6):812-818. https://doi.org/10.1136/gutjnl-2011-300154
- Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004;53(9):1244-1249. https://doi.org/10.1136/gut.2003.034629
- Zhou L, Lin S, Ding S, et al. Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study. Chinese Medical Journal 2014;127(8):1454-1458. https://doi.org/10.3760/cma.j.issn.0366-6999.20132494
- You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. Journal of the National Cancer Institute 2006;98(14):974-983. https://doi.org/10.1093/jnci/djj264
- Li WQ, Zhang JY, Ma JL, et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ (Clinical Research ed). 2019;366:l5016.
- Yoon H, Kim N, Lee HS, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter 2011;16(5):382-388. https://doi.org/10.1111/j.1523-5378.2011.00859.x
- Kim N, Park YS, Cho S-I, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter 2008;13(4):245-255. https://doi.org/10.1111/j.1523-5378.2008.00604.x
- Wang J, Xu L, Shi R, et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 2011;83(4):253-260. https://doi.org/10.1159/000280318
- Rokkas T, Rokka A, Portincasa P. A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer. Annals of Gastroenterology 2017;30(4):414-423.
- Li W-Q, Ma J-L, Zhang L, et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. JNCI: Journal of the National Cancer Institute 2014;106(7).
- Mera R, Fontham ET, Bravo LE, et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005;54(11):1536-1540. https://doi.org/10.1136/gut.2005.072009
- Yanaoka K, Oka M, Ohata H, et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. International Journal of Cancer 2009;125(11):2697-2703. https://doi.org/10.1002/ijc.24591
- de Vries AC, van Grieken NCT, Looman CWN, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008;134(4):945-952. https://doi.org/10.1053/j.gastro.2008.01.071
- Leung WK, Wong IOL, Cheung KS, et al. Effects of Helicobacter pylori treatment on incidence of gastric cancer in older individuals. Gastroenterology 2018;155(1):67-75. https://doi.org/10.1053/j.gastro.2018.03.028